Coronavirus Latest News
Serco’s annual profits surge 21% to £216m on back on Covid contracts
Increase could fund £100m in shareholder rewards as outsourcing firm bemoans ‘wildly unfair’ criticism of test and trace
Serco bemoaned “wildly unfair” criticism of its role in the much-criticised NHS Covid-19 test-and-trace scheme, as the outsourcing firm reported increased full-year profits that could fund more than £100m in shareholder rewards.
The company said it had won £700m in Covid-related contracts worldwide in 2021, taking its total pandemic-related income to £1.1bn.
Read the original article at The Guardian